Literature DB >> 6142992

Characterisation and use of an intragenic polymorphic marker for detection of carriers of haemophilia B (factor IX deficiency).

F Giannelli, D S Anson, K H Choo, D J Rees, P R Winship, N Ferrari, C R Rizza, G G Brownlee.   

Abstract

DNA from 33 healthy White subjects was analysed with a 2 X 5 kilobase subgenomic DNA probe derived from the gene for coagulation factor IX, containing the exon "d" region of that gene. Intragenic Taq I restriction-fragment length polymorphism was revealed, with allelic frequencies estimated at 0 X 65 and 0 X 35 (SE = 0 X 06), also detectable by a cDNA probe. The genomic DNA probe is technically superior to the cDNA probe and has been used in three families with haemophilia B (factor IX deficiency). The polymorphic marker segregates with the deleterious mutation, allowing the identification or exclusion of carriers. The allelic frequencies of the Taq I polymorphism are virtually ideal. Therefore, such a polymorphism should be helpful both in genetic counselling of approximately 40% of affected families and in prenatal diagnosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6142992     DOI: 10.1016/s0140-6736(84)90122-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  38 in total

1.  A new MspI restriction fragment length polymorphism in the hemophilia B locus.

Authors:  G Camerino; I Oberlé; D Drayna; J L Mandel
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

2.  MspI polymorphic site within the factor IX gene. Localization of the site and an improved method for detection.

Authors:  D L Freedenberg; S H Chen; K Kurachi; C R Scott
Journal:  Hum Genet       Date:  1987-07       Impact factor: 4.132

3.  Diagnosis of haemophilia B using the polymerase chain reaction.

Authors:  J Reiss; U Neufeldt; K Wieland; B Zoll
Journal:  Blut       Date:  1990-01

4.  Lesch-Nyhan syndrome: molecular investigation of three French Canadian families using a hypoxanthine-guanine phosphoribosyltransferase cDNA probe.

Authors:  D Sinnett; L Lavergne; S B Melançon; L Dallaire; M Potier; D Labuda
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

5.  Monoclonal antibodies to coagulation factor IX define a high-frequency polymorphism by immunoassays.

Authors:  K J Smith
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

6.  The telomeric region of the human X chromosome long arm: presence of a highly polymorphic DNA marker and analysis of recombination frequency.

Authors:  I Oberlé; D Drayna; G Camerino; R White; J L Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

7.  Evidence against close linkage of the loci for fraXq of Martin-Bell syndrome and for factor IX.

Authors:  B Zoll; J Arnemann; M Krawczak; D N Cooper; G Pescia; W Wahli; P Steinbach; J Schmidtke
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

Review 8.  Molecular genetics of the human X chromosome.

Authors:  K E Davies
Journal:  J Med Genet       Date:  1985-08       Impact factor: 6.318

9.  Gene deletion in an Italian haemophilia B subject.

Authors:  F Bernardi; L del Senno; R Barbieri; D Buzzoni; R Gambari; G Marchetti; F Conconi; F Panicucci; M Positano; S Pitruzzello
Journal:  J Med Genet       Date:  1985-08       Impact factor: 6.318

10.  Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene.

Authors:  L Grunebaum; J P Cazenave; G Camerino; C Kloepfer; J L Mandel; P Tolstoshev; M Jaye; H De la Salle; J P Lecocq
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.